BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7488032)

  • 1. The hydrophilic domain of phospholamban inhibits the Ca(2+)-ATPase--the importance of the method of assay.
    Starling AP; Hughes G; Sharma RP; East JM; Lee AG
    Biochem Biophys Res Commun; 1995 Oct; 215(3):1067-70. PubMed ID: 7488032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase.
    Coll KE; Johnson RG; McKenna E
    Biochemistry; 1999 Feb; 38(8):2444-51. PubMed ID: 10029538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of phospholamban-induced inhibition of cardiac sarcoplasmic reticulum Ca(2+)-ATPase by tannin.
    Chiesi M; Schwaller R
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1668-73. PubMed ID: 8060355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of N-terminal acetylation on Ca(2+)-ATPase inhibition by phospholamban.
    Starling AP; Sharma RP; East JM; Lee AG
    Biochem Biophys Res Commun; 1996 Sep; 226(2):352-5. PubMed ID: 8806639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+/calmodulin-dependent phosphorylation of the Ca2+-ATPase, uncoupled from phospholamban, stimulates Ca2+-pumping in native cardiac sarcoplasmic reticulum.
    Xu A; Narayanan N
    Biochem Biophys Res Commun; 1999 Apr; 258(1):66-72. PubMed ID: 10222236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition.
    Mahaney JE; Albers RW; Waggoner JR; Kutchai HC; Froehlich JP
    Biochemistry; 2005 May; 44(21):7713-24. PubMed ID: 15909986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of 6-gingerol and ellagic acid with the cardiac sarcoplasmic reticulum Ca2+-ATPase.
    Antipenko AY; Spielman AI; Kirchberger MA
    J Pharmacol Exp Ther; 1999 Jul; 290(1):227-34. PubMed ID: 10381780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.
    Hughes G; Starling AP; Sharma RP; East JM; Lee AG
    Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):973-9. PubMed ID: 8836146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca(2+)-ATPase.
    Hughes G; East JM; Lee AG
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):511-6. PubMed ID: 7980411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the calcium ion pump of sarcoplasmic reticulum: reversible inhibition by phospholamban and by the calmodulin binding domain of the plasma membrane calcium ion pump.
    Vorherr T; Chiesi M; Schwaller R; Carafoli E
    Biochemistry; 1992 Jan; 31(2):371-6. PubMed ID: 1310037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A continuous spectrophotometric assay for simultaneous measurement of calcium uptake and ATP hydrolysis in sarcoplasmic reticulum.
    Karon BS; Nissen ER; Voss J; Thomas DD
    Anal Biochem; 1995 May; 227(2):328-33. PubMed ID: 7573954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis and functional properties of the membrane-intrinsic protein phospholamban.
    Vorherr T; Wrzosek A; Chiesi M; Carafoli E
    Protein Sci; 1993 Mar; 2(3):339-47. PubMed ID: 8384040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclopiazonic acid reduces the coupling factor of the Ca2+-ATPase acting on Ca2+ binding.
    Martínez-Azorín F
    FEBS Lett; 2004 Oct; 576(1-2):73-6. PubMed ID: 15474013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved expression and characterization of Ca2+-ATPase and phospholamban in High-Five cells.
    Waggoner JR; Huffman J; Griffith BN; Jones LR; Mahaney JE
    Protein Expr Purif; 2004 Mar; 34(1):56-67. PubMed ID: 14766300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological differentiation between intracellular calcium pump isoforms.
    Engelender S; De Meis L
    Mol Pharmacol; 1996 Nov; 50(5):1243-52. PubMed ID: 8913356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic reticulum. Effects of synthetic phospholamban peptides on Ca2+ pump ATPase.
    Sasaki T; Inui M; Kimura Y; Kuzuya T; Tada M
    J Biol Chem; 1992 Jan; 267(3):1674-9. PubMed ID: 1530941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum.
    James P; Inui M; Tada M; Chiesi M; Carafoli E
    Nature; 1989 Nov; 342(6245):90-2. PubMed ID: 2530454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca-ATPase, on skeletal muscles from normal and mdx mice.
    Divet A; Lompré AM; Huchet-Cadiou C
    Acta Physiol Scand; 2005 Jul; 184(3):173-86. PubMed ID: 15954985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional effect of hydrogen peroxide on the sarcoplasmic reticulum membrane: uncoupling and irreversible inhibition of the Ca2+-ATPase protein.
    Sánchez S; Fernández-Belda F; Soler F
    Arch Biochem Biophys; 2004 Nov; 431(2):245-51. PubMed ID: 15488473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic reticulum.
    Jones LR; Field LJ
    J Biol Chem; 1993 Jun; 268(16):11486-8. PubMed ID: 8505284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.